Surrogate end points of quality of life assessment: have we really found what we are looking for?

by Tassinari, Davide
Published 2003

eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trial

by Ulivi, Paola, Scarpi, Emanuela, Passardi, Alessandro, Marisi, Giorgia, Calistri, Daniele, Zoli, Wainer, Del Re, Marzia, Frassineti, Giovanni Luca, Tassinari, Davide, Tamberi, Stefano, Vertogen, Bernadette, Amadori, Dino
Published 2015

Impact of Pre-Treatment Lactate Dehydrogenase Levels on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer

by Passardi, Alessandro, Scarpi, Emanuela, Tamberi, Stefano, Cavanna, Luigi, Tassinari, Davide, Fontana, Annalisa, Pini, Sara, Bernardini, Ilaria, Accettura, Caterina, Ulivi, Paola, Frassineti, Giovanni Luca, Amadori, Dino
Published 2015

Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer

by Passardi, Alessandro, Scarpi, Emanuela, Cavanna, Luigi, Dall'Agata, Monia, Tassinari, Davide, Leo, Silvana, Bernardini, Ilaria, Gelsomino, Fabio, Tamberi, Stefano, Brandes, Alba A., Tenti, Elena, Vespignani, Roberto, Frassineti, Giovanni L., Amadori, Dino, De Giorgi, Ugo
Published 2016